Drowsiness in Clopra - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Drowsiness, when it was recovered, drug effectiveness, race, and more among people who take Clopra (metoclopramide hydrochloride). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Clopra?

Clopra has active ingredients of metoclopramide hydrochloride. eHealthMe is studying from 81,430 Clopra users. Check the latest studies of Clopra.

What is Drowsiness?

Drowsiness is found to be associated with 2,867 drugs and 4,797 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Jul, 29, 2026

15 people who have Drowsiness while taking Clopra were studied.

Severity of Drowsiness *:

least: 7.14 %
moderate: 57.14 %
severe: 35.71 %
most severe: 0.0 %

When people recovered from Drowsiness *:

while on drug: 0.0 %
after off the drug: 0.0 %
not yet: 100 %

Effectiveness of Clopra *:

not at all: 0.0 %
somewhat: 14.29 %
moderate: 42.86 %
high: 28.57 %
very high: 14.29 %

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 10 %
Asian: 10 %
Hispanic: 10 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 70 %

Time on Clopra *:

Gender of people when taking Clopra *:

female: 53.33 %
male: 46.67 %

Age of people when taking Clopra *:

Conditions people have *:

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 46.67%
Nausea (feeling of having an urge to vomit): 4 people, 26.67%
Depression: 3 people, 20.00%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 20.00%
Nausea And Vomiting: 3 people, 20.00%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 13.33%
Gastroparesis (delayed emptying of food from the stomach): 2 people, 13.33%
Type 2 Diabetes: 2 people, 13.33%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 13.33%
Insomnia (sleeplessness): 2 people, 13.33%

Other drugs people take besides Clopra *:

Other side effects people have besides Drowsiness *:

Hyperhidrosis (abnormally increased sweating): 3 people, 20.00%
Insomnia (sleeplessness): 3 people, 20.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 13.33%
Diarrhea: 2 people, 13.33%
Headache (pain in head): 2 people, 13.33%
Tardive Dyskinesia (a disorder that involves involuntary movements): 2 people, 13.33%
Agitation (state of anxiety or nervous excitement): 2 people, 13.33%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 13.33%
Erection Problems: 2 people, 13.33%
Frequent Or Urgent Urination: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Clopra and have Drowsiness?

Check whether Drowsiness is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drowsiness in Clopra

How the study uses the data?

The study is based on metoclopramide hydrochloride (the active ingredients of Clopra). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.